Korea-China Patent Offices Jointly Analyze Patent Information on COVID-19 Response

Park Won-joo, Commissioner of the Korean Intellectual Property Office (left), is holding a video conference with Shen Changwei, Commissioner of the China National Intellectual Property Administration, at the Government Complex Daejeon on the 9th. Photo by the Korean Intellectual Property Office

[Asia Economy (Daejeon) Reporter Jeong Il-woong] The Korean Intellectual Property Office (KIPO) and the China National Intellectual Property Administration (CNIPA) will mutually cooperate in analyzing patent information related to the novel coronavirus infection (COVID-19).

On the 9th, KIPO announced that Commissioner Park Won-joo and CNIPA Commissioner Shen Changyu agreed on joint analysis of patent information between the two countries' patent offices during a video conference.

During the video conference, the heads of the two patent offices shared the current status of patent information analysis on COVID-19 data, diagnosis, and quarantine being conducted individually in each country, and agreed to carry out effective joint analysis work by leveraging each other's strengths going forward.

First, Commissioner Park emphasized, "Patent data serves as a reference that helps systematically verify past science and technology, and it plays a role in solving urgent issues faced by both countries."

He also stated, "I propose that by sharing and developing know-how in patent information analysis, the two countries contribute to overcoming the COVID-19 crisis."

In response, Commissioner Shen said, "Through cooperation in patent information analysis between the two countries, we expect to provide more valuable information not only to researchers in Korea and China but also worldwide," and added, "Let us start by sharing COVID-19 related analysis results and initiate full-scale cooperation between the two patent offices."

Previously, KIPO has provided the latest domestic and international patent technologies and patent trend reports by field such as treatment, diagnosis, and quarantine through the COVID-19 Patent Information Navigation, while China has opened a patent information sharing portal to disclose research analysis reports on related technologies.

Based on this, KIPO expects that Korea’s detailed analysis in the diagnosis field for respiratory infections and China’s uniqueness in prevention and treatment using traditional herbal medicine will create a synergy effect when the two countries engage in joint analysis work.

Commissioner Park Won-joo said, "Since the early stages of COVID-19, Korea and China have cooperated at both government and private levels, including mutual support of quarantine supplies," and added, "With the joint patent information analysis work by the two patent offices, we expect to contribute to resolving the current global crisis and to advance patent information analysis methods to a new level."

This content was produced with the assistance of AI translation services.